James I. Cleeman
Impact in
- Endocrinology, Diabetes and Metabolism top 0.02%
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diet, Metabolism, and Disease
Papers in
- Surgery 18
- Lipoproteins and Cardiovascular Health 17
- Cholesterol and Lipid Metabolism 2
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 16
- Diet, Metabolism, and Disease 3
- Diabetes Management and Research 2
- Co-authors
- Scott M. Grundy (18 shared papers)Sidney C. Smith (8 shared papers)Sidney C. Smith (7 shared papers)Karen A. Donato (5 shared papers)Robert H. Eckel (5 shared papers)H Bryan Brewer (6 shared papers)Claude Lenfant (8 shared papers)Jean‐Charles Fruchart (1 shared paper)
- Journals
- Circulation (13 papers)Arteriosclerosis Thrombosis and Vascular Biology (3 papers)Journal of the American College of Cardiology (2 papers)The Journal of the American Osteopathic Association (1 paper)Current Opinion in Lipidology (1 paper)
- Partner nations
- United StatesAustraliaGermany
In The Last Decade
James I. Cleeman
40 papers receiving 37.9k citations
James I. Cleeman's Hit Papers
Peers
Comparison fields: 5 of 174
- Endocrinology, Diabetes and Metabolism 10.4k
- Cardiology and Cardiovascular Medicine 5.4k
- Physiology 4.9k
- Epidemiology 5.4k
- Surgery 6.5k
Countries citing papers authored by James I. Cleeman
This map shows the geographic impact of James I. Cleeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James I. Cleeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James I. Cleeman more than expected).
Fields of papers citing papers by James I. Cleeman
This network shows the impact of papers produced by James I. Cleeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James I. Cleeman. The network helps show where James I. Cleeman may publish in the future.
Co-authors
The 25 scholars most cited alongside James I. Cleeman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Harmonizing the Metabolic Syndrome Hit paper breakdown → | 2009 | 11353 |
| 2 | Diagnosis and Management of the Metabolic Syndrome Hit paper breakdown → | 2005 | 9602 |
| 3 | Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines Hit paper breakdown → | 2004 | 5263 |
| 4 | Definition of Metabolic Syndrome Hit paper breakdown → | 2004 | 4848 |
| 5 | Diagnosis and Management of the Metabolic Syndrome Hit paper breakdown → | 2005 | 1329 |
| 6 | Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines Hit paper breakdown → | 2004 | 1187 |
| 7 | ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins Hit paper breakdown → | 2002 | 837 |
| 8 | Diagnosis and Management of the Metabolic Syndrome Hit paper breakdown → | 2005 | 663 |
| 9 | Clinical Management of Metabolic Syndrome Hit paper breakdown → | 2004 | 653 |
| 10 | Definition of Metabolic Syndrome Hit paper breakdown → | 2004 | 632 |
| 11 | The National Cholesterol Education Program Hit paper breakdown → | 1989 | 544 |
| 12 | 2002 | 376 | |
| 13 | 2005 | 371 | |
| 14 | 1998 | 312 | |
| 15 | 2002 | 185 | |
| 16 | 2004 | 165 | |
| 17 | 2004 | 150 | |
| 18 | Highlights of the report of the expert panel on blood cholesterol levels in children and adolescents | 1992 | 132 |
| 19 | 2001 | 115 | |
| 20 | 1998 | 113 |
About James I. Cleeman
James I. Cleeman is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism, Economics and Econometrics, Cardiology and Cardiovascular Medicine and Pharmacology, having authored 40 papers that have together received 39.3k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (17 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (16 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers), Pharmacology and Obesity Treatment (4 papers), Diet, Metabolism, and Disease (3 papers), Lipid metabolism and disorders (3 papers), Diabetes Management and Research (2 papers) and Cholesterol and Lipid Metabolism (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (10.4k citations), Cardiology and Cardiovascular Medicine (5.4k citations), Physiology (4.9k citations), Epidemiology (5.4k citations) and Surgery (6.5k citations). James I. Cleeman has collaborated with scholars based in United States, Australia and Germany. Frequent co-authors include Scott M. Grundy, Sidney C. Smith, Sidney C. Smith, Karen A. Donato, Robert H. Eckel, H Bryan Brewer, Claude Lenfant, Jean‐Charles Fruchart, W. P. T. James and K. G. M. M. Alberti. Their work appears in journals such as Circulation, Arteriosclerosis Thrombosis and Vascular Biology, Journal of the American College of Cardiology, The Journal of the American Osteopathic Association and Current Opinion in Lipidology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.